Interplay between MITF, PIAS3, and STAT3 in Mast Cells and Melanocytes

REFERENCES

• Bowman, T., Broome M. A., Sinibaldi D., Wharton W., Pledger W. J., Sedivy J. M., Irby R., Yeatman T., Courtneidge S. A., and Jove R.. 2001. Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis. Proc. Natl. Acad. Sci. USA 98:7319–7324.
   PubMed Web of Science ®Google Scholar
• Bowman, T., Garcia R., Turkson J., and Jove R.. 2000. STATs in oncogenesis. Oncogene 19:2474–2488.
   PubMed Web of Science ®Google Scholar
• Bromberg, J. F., Wrzeszczynska M. H., Devgan G., Zhao Y., Pestell R. G., Albanese C., and Darnell J. E., Jr. 1999. Stat3 as an oncogene. Cell 98:295–303.
   PubMed Web of Science ®Google Scholar
• Darnell, J. E., Jr., Kerr I. M., and Stark G. R.. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415–1421.
   PubMed Web of Science ®Google Scholar
• Dorvault, C. C., Weilbaecher K. N., Yee H., Fisher D. E., Chiriboga L. A., Xu Y., and Chhieng D. C.. 2001. Microphthalmia transcription factor: a sensitive and specific marker for malignant melanoma in cytologic specimens. Cancer 93:337–343.
   PubMedGoogle Scholar
• Duval, D., Duval G., Kedinger C., Poch O., and Boeuf H.. 2003. The “PINIT” motif, of a newly identified conserved domain of the PIAS protein family, is essential for nuclear retention of PIAS3L. FEBS Lett. 554:111–118.
   PubMed Web of Science ®Google Scholar
• Fumo, G., Akin C., Metcalfe D. D., and Neckers L.. 2004. 17-Allylamino-17-demethoxygeldanamycin (17-AAG) is effective in down-regulating mutated, constitutively activated KIT protein in human mast cells. Blood 103:1078–1084.
   PubMed Web of Science ®Google Scholar
• Goldstein, R. E., Jimenez G., Cook O., Gur D., and Paroush Z.. 1999. Huckebein repressor activity in Drosophila terminal patterning is mediated by Groucho. Development 126:3747–3755.
   PubMedGoogle Scholar
• Gommerman, J. L., and Berger S. A.. 1998. Protection from apoptosis by steel factor but not interleukin-3 is reversed through blockade of calcium influx. Blood 91:1891–1900.
   PubMed Web of Science ®Google Scholar
• Grandis, J. R., Drenning S. D., Zeng Q., Watkins S. C., Melhem M. F., Endo S., Johnson D. E., Huang L., He Y., and Kim J. D.. 2000. Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. Proc. Natl. Acad. Sci. USA 97:4227–4232.
   PubMed Web of Science ®Google Scholar
• Gross, M., Liu B., Tan J., French F. S., Carey M., and Shuai K.. 2001. Distinct effects of PIAS proteins on androgen-mediated gene activation in prostate cancer cells. Oncogene 20:3880–3887.
   PubMed Web of Science ®Google Scholar
• Gyotoku, E., Morita E., Kameyoshi Y., Hiragun T., Yamamoto S., and Hide M.. 2001. The IL-6 family cytokines, interleukin-6, interleukin-11, oncostatin M, and leukemia inhibitory factor, enhance mast cell growth through fibroblast-dependent pathway in mice. Arch. Dermatol. Res. 293:508–514.
   PubMedGoogle Scholar
• Hallsson, J. H., Favor J., Hodgkinson C., Glaser T., Lamoreux M. L., Magnusdottir R., Gunnarsson G. J., Sweet H. O., Copeland N. G., Jenkins N. A., and Steingrimsson E.. 2000. Genomic, transcriptional and mutational analysis of the mouse microphthalmia locus. Genetics 155:291–300.
   PubMedGoogle Scholar
• Hemesath, T. J., Price E. R., Takemoto C., Badalian T., and Fisher D. E.. 1998. MAP kinase links the transcription factor microphthalmia to c-Kit signaling in melanocytes. Nature 391:298–301.
   PubMed Web of Science ®Google Scholar
• Hirano, T. 1998. Interleukin 6 and its receptor: ten years later. Int. Rev. Immun. 16:249–284.
   PubMed Web of Science ®Google Scholar
• Hirano, T., Ishihara K., and Hibi M.. 2000. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 19:2548–2556.
   PubMed Web of Science ®Google Scholar
• Hodgkinson, C. A., Moore K. J., Nakayama A., Steingrimsson E., Copeland N. G., Jenkins N. A., and Arnheiter H.. 1993. Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell 74:395–404.
   PubMed Web of Science ®Google Scholar
• Hoeffler, W. K., Levinson A. D., and Bauer E. A.. 1994. Activation of c-Jun transcription factor by substitution of a charged residue in its N-terminal domain. Nucleic Acids Res. 22:1305–1312.
   PubMedGoogle Scholar
• Hughes, M. J., B. L. J., Krakowsky J. M., and Anderson K. P.. 1993. A helix-loop-helix transcription factor-like gene is located at the mi locus. J. Biol. Chem. 268:20687–20690.
   PubMed Web of Science ®Google Scholar
• Isozaki, K., Tsujimura T., Nomura S., Morii E., Koshimizu U., Nishimune Y., and Kitamura Y.. 1994. Cell type-specific deficiency of c-kit gene expression in mutant mice of mi/mi genotype. Am. J. Pathol. 145:827–836.
   PubMedGoogle Scholar
• Ito, A., Morii E., Kim D. K., Kataoka T. R., Jippo T., Maeyama K., Nojima H., and Kitamura Y.. 1999. Inhibitory effect of the transcription factor encoded by the mi mutant allele in cultured mast cells of mice. Blood 93:1189–1196.
   PubMedGoogle Scholar
• Jackson, P. K. 2001. A new RING for SUMO: wrestling transcriptional responses into nuclear bodies with PIAS family E3 SUMO ligases. Genes Dev. 15:3053–3058.
   PubMedGoogle Scholar
• Jippo, T., Morii E., Ito A., and Kitamura Y.. 2003. Effect of anatomical distribution of mast cells on their defense function against bacterial infections: demonstration using partially mast cell-deficient tg/tg mice. J. Exp. Med. 197:1417–1425.
   PubMedGoogle Scholar
• Kamaraju, A. K., Bertolotto C., Chebath J., and Revel M.. 2002. Pax3 down-regulation and shut-off of melanogenesis in melanoma B16/F10.9 by interleukin-6 receptor signaling. J. Biol. Chem. 277:15132–15141.
   PubMed Web of Science ®Google Scholar
• Kaptein, A., Paillard V., and Saunders M.. 1996. Dominant negative stat3 mutant inhibits interleukin-6-induced Jak-STAT signal transduction. J. Biol. Chem. 271:5961–5964.
   PubMedGoogle Scholar
• Kitamura, Y., Morii E., Jippo T., and Ito A.. 2002. Effect of MITF on mast cell differentiation. Mol. Immunol. 38:1173–1176.
   PubMedGoogle Scholar
• Levy, C., Nechushtan H., and Razin E.. 2002. A new role for the STAT3 inhibitor, PIAS3: a repressor of microphthalmia transcription factor. J. Biol. Chem. 277:1962–1966.
   PubMedGoogle Scholar
• Levy, C., Sonnenblick A., and Razin E.. 2003. The role played by MITF phosphorylation and its Zip domain in its transcriptional inhibition by PIAS3. Mol. Cell. Biol. 23:9073–9080.
   PubMedGoogle Scholar
• Linnekin, D. 1999. Early signaling pathways activated by c-Kit in hematopoietic cells. Int. J. Biochem. Cell Biol. 31:1053–1074.
   PubMed Web of Science ®Google Scholar
• Liu, B., Gross M., ten Hoeve J., and Shuai K.. 2001. A transcriptional corepressor of Stat1 with an essential LXXLL signature motif. Proc. Natl. Acad. Sci. USA 98:3203–3207.
   PubMedGoogle Scholar
• McGill, G. G., Horstmann M., Widlund H. R., Du J., Motyckova G., Nishimura E. K., Lin Y. L., Ramaswamy S., Avery W., Ding H. F., Jordan S. A., Jackson I. J., Korsmeyer S. J., Golub T. R., and Fisher D. E.. 2002. Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. Cell 109:707–718.
   PubMed Web of Science ®Google Scholar
• Moore, K. J. 1995. Insight into the microphthalmia gene. Trends Genet. 11:442–450.
   PubMed Web of Science ®Google Scholar
• Morii, E., Jippo T., Hashimoto K., Kim D.-K., Lee Y.-M., Ogihara H., Tsujino K., Kim H.-M., and Kitamura Y.. 1997. Abnormal expression of mouse mast cell protease 5 gene in cultured mast cells derived from mutant mi/mi mice. Blood 90:3057–3066.
   PubMedGoogle Scholar
• Morii, E., Ogihara H., Oboki K., Kataoka T. R., Maeyama K., Fisher D. E., Lamoreux M. L., and Kitamura Y.. 2001. Effect of a large deletion of the basic domain of mi transcription factor on differentiation of mast cells. Blood 98:2577–2579.
   PubMedGoogle Scholar
• Morii, E., Tsujimura T., Jippo T., Hashimoto K., Takebayashi K., Tsujino K., Nomura S., Yamamoto M., and Kitamura Y.. 1996. Regulation of mouse mast cell protease 6 gene expression by transcription factor encoded by the mi locus. Blood 88:2488–2494.
   PubMedGoogle Scholar
• Razin, E., Cardon-Cardo C., and Good R. A.. 1981. Growth of a pure population of mouse mast cells in vitro using conditioned medium derived from Con A-stimulated splenocytes. Proc. Natl. Acad. Sci. USA 78:2559–2561.
   PubMedGoogle Scholar
• Razin, E., Zhang Z. C., Nechushtan H., Frenkel S., Lee Y. N., Arudchandran R., and Rivera J.. 1999. Suppression of microphthalmia transcriptional activity by its association with protein kinase C-interacting protein 1 in mast cells. J. Biol. Chem. 274:34272–34276.
   PubMedGoogle Scholar
• Rodel, B., Tavassoli K., Karsunky H., Schmidt T., Bachmann M., Schaper F., Heinrich P., Shuai K., Elsasser H. P., and Moroy T.. 2000. The zinc finger protein Gfi-1 can enhance STAT3 signaling by interacting with the STAT3 inhibitor PIAS3. EMBO J. 19:5845–5855.
   PubMed Web of Science ®Google Scholar
• Sinibaldi, D., Wharton W., Turkson J., Bowman T., Pledger W. J., and Jove R.. 2000. Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling. Oncogene 19:5419–5427.
   PubMed Web of Science ®Google Scholar
• Tachibana, M., Takeda K., Nobukuni Y., Urabe K., Long J. E., Meyers K. A., Aaronson S. A., and Miki T.. 1996. Ectopic expression of MITF, a gene for Waardenburg syndrome type 2, converts fibroblasts to cells with melanocyte characteristics. Nat. Genet. 14:50–54.
   PubMed Web of Science ®Google Scholar
• Takeda, K., Noguchi K., Shi W., Tanaka T., Matsumoto M., Yoshida N., Kishimoto T., and Akira S.. 1997. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc. Natl. Acad. Sci. USA 94:3801–3804.
   PubMed Web of Science ®Google Scholar
• Takeda, K., Takemoto C., Kobayashi I., Watanabe A., Nobukuni Y., Fisher D. E., and Tachibana M.. 2000. Ser298 of MITF, a mutation site in Waardenburg syndrome type 2, is a phosphorylation site with functional significance. Hum. Mol. Genet. 9:125–132.
   PubMedGoogle Scholar
• Weilbaecher, K. N., Hershey C. L., Takemoto C. M., Horstmann M. A., Hemesath T. J., Tashjian A. H., and Fisher D. E.. 1998. Age-resolving osteopetrosis: a rat model implicating microphthalmia and the related transcription factor TFE3. J. Exp. Med. 187:775–785.
   PubMedGoogle Scholar
• Weilbaecher, K. N., Motyckova G., Huber W. E., Takemoto C. M., Hemesath T. J., Xu Y., Hershey C. L., Dowland N. R., Wells A. G., and Fisher D. E.. 2001. Linkage of M-CSF signaling to Mitf, TFE3, and the osteoclast defect in Mitfmi/mi mice. Mol. Cell 8:749–758.
   PubMedGoogle Scholar
• Wittekind, M., Reizer J., Deutscher J., Saier M. H., and Klevit R. E.. 1989. Common structural changes accompany the functional inactivation of HPr by seryl phosphorylation or by serine to aspartate substitution. Biochemistry 28:9908–9912.
   PubMedGoogle Scholar
• Wu, M., Hemesath T. J., Takemoto C. M., Horstmann M. A., Wells A. G., Price E. R., Fisher D. Z., and Fisher D. E.. 2000. c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi. Genes Dev. 14:301–312.
   PubMed Web of Science ®Google Scholar
• Yanagida, M., Fukamachi H., Ohgami K., Kuwaki T., Ishii H., Uzumaki H., Amano K., Tokiwa T., Mitsui H., Saito H., et al. 1995. Effects of T-helper 2-type cytokines, interleukin-3 (IL-3), IL-4, IL-5, and IL-6 on the survival of cultured human mast cells. Blood 86:3705–3714.
   PubMedGoogle Scholar